Utah Medical Products, Inc.
UTMDNASDAQHealthcareMedical Instruments & Supplies
As of Oct 23, 2026 close
- Market cap
- $236.32M
- P/E (TTM)
- 22.54
- Forward P/E
- 27.37
- Dividend yield
- 1.65%
- 52-week range
- $53.66$76.89
- Volume (live)
- -
- Avg. volume (3M)
- 38.90K
Utah Medical Products (UTMD) Stock Price & Financial Analysis
Utah Medical Products Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $74.04 - $75.13 |
|---|---|
| 52-Week High | $76.89 |
| 52-Week Low | $53.66 |
| Open | $75.13 |
| Volume (last close) | 38.39K |
| Average Volume (3M) | 38.90K |
| Revenue (TTM) | 36.11M |
|---|---|
| Net Income (TTM) | 10.49M |
| Free Cash Flow (TTM) | 11.45M |
| EPS (TTM) | $3.28 |
| Profit Margin | 29.04% |
| Operating Margin | 28.43% |
| Return on Equity (ROE) | 8.59% |
| Debt to Equity | 0.00 |
| Annual Dividend | $1.24 |
|---|---|
| Dividend Yield | 1.65% |
| Payout Ratio | 37.77% |
| Last Dividend Ex-Date | Sep 17, 2026 |
| Market Cap | 236.32M |
|---|---|
| Shares Outstanding | 3.18M |
| P/E Ratio (TTM) | 22.54 |
| Forward P/E | 27.37 |
| Price to Sales (P/S) | 6.54 |
| Price to Book (P/B) | 1.94 |
| EV/EBITDA | 10.48 |
| 50-Day MA | $72.87 |
|---|---|
| 200-Day MA | $67.54 |
| 1-Year Change | +24.17% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Utah Medical Products at a Glance
As of the Oct 23, 2026 close, Utah Medical Products (UTMD) has a market capitalization of $236.32M. The stock trades at 22.5× trailing earnings, 27.4× forward earnings and 6.5× sales. Over the trailing twelve months it earned $10.49M on revenue of $36.11M (a 29.0% profit margin) and generated $11.45M of free cash flow. Revenue fell 7.0% year over year.
As of its latest reported balance sheet, it holds $87.53M in cash and securities against $195.00K of debt, a net cash position of $87.33M.
Utah Medical Products pays a quarterly dividend totaling $1.24 per share a year, a 1.65% yield at the Oct 23, 2026 close, with a 38% payout ratio and 21 consecutive years of dividend increases.
The share price is up 24.2% over the past year. At $74.23 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $53.66 to $76.89, above its 200-day moving average of $67.54.
Frequently Asked Questions About Utah Medical Products
What is the current stock price for UTMD?
As of the Oct 23, 2026 close, UTMD stock trades at $74.23. The 52-week range is $53.66–$76.89, with a day range of $74.04–$75.13.
What is the P/E ratio for UTMD?
As of the Oct 23, 2026 close, Utah Medical Products's trailing twelve-month (TTM) P/E ratio is 22.5, meaning investors pay $22.5 for every $1 of annual earnings. The forward P/E is 27.4, reflecting analyst expectations for future earnings. Utah Medical Products operates in the Healthcare sector.
Does UTMD pay dividends?
Yes, Utah Medical Products pays a 1.65% annual dividend yield as of the Oct 23, 2026 close ($1.24 per share a year). The trailing twelve-month payout ratio is 37.8%. The most recent ex-dividend date was September 17, 2026.
What do analysts recommend for UTMD?
Analyst ratings and recommendations for UTMD are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of UTMD?
As of the Oct 23, 2026 close, Utah Medical Products's market capitalization is $236.3M, classifying it as a micro-cap company. Utah Medical Products operates in the Healthcare sector within the Medical Instruments & Supplies industry.